Abstract
Objectives
Urine albumin is a key biomarker utilized for diagnosis and monitoring progression of chronic kidney disease (CKD). These characteristics highlight the importance urine albumin serves in patient management. However, laboratory results are confounded by a lack of standardization where results may exceed 40 % difference between diagnostic platforms. This presents serious issues since current guideline clinical decision points are fixed values and misclassification may occur between laboratory methods. Therefore, standardization is needed for urine albumin measurements.
Methods
A liquid chromatography tandem mass spectrometry (LC-MS/MS) reference measurement procedure (RMP) was developed. This RMP employed proteolysis using trypsin and examined six peptides specific to human serum albumin. The National Institute of Standards and Technology 2925 reference material was used to value assign calibrators. To improve imprecision and accuracy, all samples were run in quadruplicate. Urine from 98 patient specimens was analyzed.
Results
RMP final results consisted of averaging four peptide transitions, yielding a 20-day coefficient of variation (CV) of <3.0 %. Factors considered in assigning RMP overall uncertainty included specimen and internal standard pipetting, calibration material, and LC-MS/MS imprecision. This RMP was compared to the Roche Cobas and Siemens Dimension Vista urine albumin assays and was found to have a −9.9 and 20.1 % bias, respectively. This RMP was found to have equivalent results to two other RMPs in a previous study.
Conclusions
This RMP demonstrated excellent imprecision, achieving an overall CV of 2.8 % and meeting the CV ≤6.2 % performance specification required for standardizing urine albumin measurements in clinical laboratories.
Funding source: National Institutes of Health National Center for Advancing Translational Sciences
Award Identifier / Grant number: Grant UM1TR004405
Acknowledgments
We acknowledge the NIDDK Urine Albumin Standardization laboratory working group along with Drs. W. Greg Miller and John H. Eckfeldt for helpful input and conversations.
-
Research ethics: Study was approved by the University of Minnesota Institutional Review Board and classified exempt as there were no patient identifiers obtained and specimens were deidentified.
-
Informed consent: Not applicable as study was classified as minimal risk and exempt by IRB.
-
Author contributions: JCS: Corresponding author, study design, writing, data workup and interpretation. SS: Writing, data workup, and submission. ZS: Writing and data workup. ME: Statistical advisor. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: JCS serves as a consultant for Abbott Laboratories and Nephrolyx. All other authors state no conflict of interest.
-
Research funding: Statistical analysis was supported in part by the National Institutes of Health’s National Center for Advancing Translational Sciences, grant UM1TR004405. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health’s National Center for Advancing Translational Sciences.
-
Data availability: All data generated or analyzed during this study are included in this published article [and its Supplementary Information files].
References
1. US Department of Health and Human Services, Centers for Disease Control and Prevention. Chronic kidney disease in the United States, 2023. Available from: https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html.Accesed:12-20-20232023.Search in Google Scholar
2. Kovesdy, CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 2022;12:7–11. https://doi.org/10.1016/j.kisu.2021.11.003.Search in Google Scholar PubMed PubMed Central
3. Sundström, J, Bodegard, J, Bollmann, A, Vervloet, MG, Mark, PB, Karasik, A, et al.. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study. Lancet Reg Health Europe 2022;20:1–14.10.1016/j.lanepe.2022.100438Search in Google Scholar PubMed PubMed Central
4. Stevens, PE, Ahmed, SB, Carrero, JJ, Foster, B, Francis, A, Hall, RK, et al.. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105:S117–314. https://doi.org/10.1016/j.kint.2023.10.018.Search in Google Scholar PubMed
5. de Boer, IH, Khunti, K, Sadusky, T, Tuttle, KR, Neumiller, JJ, Rhee, CM, et al.. Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO) | diabetes care | American diabetes association. Diabetes Care 2022;45:3075–90. https://doi.org/10.2337/dci22-0027.Search in Google Scholar PubMed PubMed Central
6. Myers, GL. Standardization of serum creatinine measurement: theory and practice. Scandinavian journal of clinical and laboratory investigation. Supplement 2008;241:57–63.10.1080/00365510802149887Search in Google Scholar PubMed
7. Bachmann, LM, Nilsson, G, Bruns, DE, McQueen, MJ, Lieske, JC, Zakowski, JJ, et al.. State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry. Clin Chem 2014;60:471–80. https://doi.org/10.1373/clinchem.2013.210302.Search in Google Scholar PubMed
8. Seegmiller, JC, Miller, WG, Bachmann, LM. Moving toward standardization of urine albumin measurements. EJIFCC 2017;28:258–67.Search in Google Scholar
9. Seegmiller, JC, Ix, JH. Rethinking albuminuria in low-risk patients and a call for urine albumin standardization. Clin Chem 2025;71. https://doi.org/10.1093/clinchem/hvae157.Search in Google Scholar PubMed
10. Kinumi, T, Skaguchi, Y, Takatsu, A. Development of a certified reference material of human serum albumin: certification and value assignment via amino acid analyses. Anal Methods 2017;9:4574–80. https://doi.org/10.1039/c7ay01415e.Search in Google Scholar
11. Green, A, Bunk, D, Zhang, N, Alejo, W. Certification of standard reference material ® 174; 2925. In: Recombinant human serum albumin solution (primary reference calibrator for urine albumin) (Frozen). Gaithersburg, MD: Special Publication (NIST SP); 2020.Search in Google Scholar
12. Green, A, Camara, J, Heckert, N. Certification of standard reference Material® 3666 albumin and creatinine in frozen human urine. Gaithersburg, MD: Special Publication (NIST SP); 2023.10.6028/NIST.SP.260-238Search in Google Scholar
13. Certified reference materials health Sciences authority chemical Metrology laboratory date of issue 25 apr 2024. Available from: https://www.hsa.gov.sg/docs/default-source/chemical-metrology/hsa-crm-brochure-(25-apr-2024).pdf?sfvrsn=2f5f0a05_3/hsa-crm-brochure-(25-apr-2024).pdf.Accesed:11-19-2024 2024.Search in Google Scholar
14. Miller, WG, Bruns, DE. Laboratory issues in measuring and reporting urine albumin. Nephrol Dial Transplant. official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24. https://doi.org/10.1093/ndt/gfp022.Search in Google Scholar PubMed
15. Seegmiller, JC, Barnidge, DR, Burns, BE, Larson, TS, Lieske, JC, Kumar, R. Quantification of urinary albumin by using protein cleavage and LC-MS/MS. Clin Chem 2009;55:1100–7. https://doi.org/10.1373/clinchem.2008.115543.Search in Google Scholar PubMed PubMed Central
16. Beasley-Green, A, Burris, NM, Bunk, DM, Phinney, KW. Multiplexed LC-MS/MS assay for urine albumin. J Proteome Res 2014;13:3930–9. https://doi.org/10.1021/pr500204c.Search in Google Scholar PubMed
17. Chen, Y, Liu, H, Loh, TP, Liu, Q, Teo, TL, Lee, TK, et al.. Measurement of urine albumin by liquid chromatography-isotope dilution tandem mass spectrometry and its application to value assignment of external quality assessment samples and certification of reference materials. Clin Chem Lab Med 2020;59:711–20. https://doi.org/10.1515/cclm-2020-0969.Search in Google Scholar PubMed
18. Miller, WG, Bachmann, LM, Budd, J, Beasley-Green, A, Phinney, KW, Tan, HT, et al.. Extent of equivalence of results for urine albumin among 3 candidate mass spectrometry reference measurement procedures. Clin Chem 2024;70. https://doi.org/10.1093/clinchem/hvae122.Search in Google Scholar PubMed
19. Verma, A, Schmidt, IM, Claudel, S, Palsson, R, Waikar, SS, Srivastava, A. Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria: a cohort study. Ann Intern Med 2024;177:467–76. https://doi.org/10.7326/m23-2814.Search in Google Scholar PubMed PubMed Central
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cclm-2024-1374).
© 2025 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Setting analytical performance specification by simulation (Milan model 1b)
- Reviews
- Unveiling the power of R: a comprehensive perspective for laboratory medicine data analysis
- Clostebol detection after transdermal and transmucosal contact. A systematic review
- Opinion Papers
- A value-based score for clinical laboratories: promoting the work of the new EFLM committee
- Digital metrology in laboratory medicine: a call for bringing order to chaos to facilitate precision diagnostics
- Perspectives
- Supporting prioritization efforts of higher-order reference providers using evidence from the Joint Committee for Traceability in Laboratory Medicine database
- Clinical vs. statistical significance: considerations for clinical laboratories
- Genetics and Molecular Diagnostics
- Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction
- Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS
- Candidate Reference Measurement Procedures and Materials
- Liquid chromatography tandem mass spectrometry (LC-MS/MS) candidate reference measurement procedure for urine albumin
- General Clinical Chemistry and Laboratory Medicine
- Patient risk management in laboratory medicine: an international survey to assess the severity of harm associated with erroneous reported results
- Exploring the extent of post-analytical errors, with a focus on transcription errors – an intervention within the VIPVIZA study
- A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe
- Quality indicators in laboratory medicine: a 2020–2023 experience in a Chinese province
- Impact of delayed centrifugation on the stability of 32 biochemical analytes in blood samples collected in serum gel tubes and stored at room temperature
- Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study
- Novel protocol for metabolomics data normalization and biomarker discovery in human tears
- Use of the BIOGROUP® French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study
- Reference Values and Biological Variations
- Consensus instability equations for routine coagulation tests
- Hematology and Coagulation
- Flow-cytometric lymphocyte subsets enumeration: comparison of single/dual-platform method in clinical laboratory with dual-platform extended PanLeucogating method in reference laboratory
- Cardiovascular Diseases
- Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study
- Infectious Diseases
- Cell population data for early detection of sepsis in patients with suspected infection in the emergency department
- Letters to the Editor
- Lab Error Finder: A call for collaboration
- Cascading referencing of terms and definitions
- Strengthening international cooperation and confidence in the field of laboratory medicine by ISO standardization
- Determining the minimum blood volume required for laboratory testing in newborns
- Performance evaluation of large language models with chain-of-thought reasoning ability in clinical laboratory case interpretation
- Vancomycin assay interference: low-level IgM paraprotein disrupts Siemens Atellica® CH VANC assay
- Dr. Morley Donald Hollenberg. An extraordinary scientist, teacher and mentor
Articles in the same Issue
- Frontmatter
- Editorial
- Setting analytical performance specification by simulation (Milan model 1b)
- Reviews
- Unveiling the power of R: a comprehensive perspective for laboratory medicine data analysis
- Clostebol detection after transdermal and transmucosal contact. A systematic review
- Opinion Papers
- A value-based score for clinical laboratories: promoting the work of the new EFLM committee
- Digital metrology in laboratory medicine: a call for bringing order to chaos to facilitate precision diagnostics
- Perspectives
- Supporting prioritization efforts of higher-order reference providers using evidence from the Joint Committee for Traceability in Laboratory Medicine database
- Clinical vs. statistical significance: considerations for clinical laboratories
- Genetics and Molecular Diagnostics
- Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction
- Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS
- Candidate Reference Measurement Procedures and Materials
- Liquid chromatography tandem mass spectrometry (LC-MS/MS) candidate reference measurement procedure for urine albumin
- General Clinical Chemistry and Laboratory Medicine
- Patient risk management in laboratory medicine: an international survey to assess the severity of harm associated with erroneous reported results
- Exploring the extent of post-analytical errors, with a focus on transcription errors – an intervention within the VIPVIZA study
- A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe
- Quality indicators in laboratory medicine: a 2020–2023 experience in a Chinese province
- Impact of delayed centrifugation on the stability of 32 biochemical analytes in blood samples collected in serum gel tubes and stored at room temperature
- Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study
- Novel protocol for metabolomics data normalization and biomarker discovery in human tears
- Use of the BIOGROUP® French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study
- Reference Values and Biological Variations
- Consensus instability equations for routine coagulation tests
- Hematology and Coagulation
- Flow-cytometric lymphocyte subsets enumeration: comparison of single/dual-platform method in clinical laboratory with dual-platform extended PanLeucogating method in reference laboratory
- Cardiovascular Diseases
- Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study
- Infectious Diseases
- Cell population data for early detection of sepsis in patients with suspected infection in the emergency department
- Letters to the Editor
- Lab Error Finder: A call for collaboration
- Cascading referencing of terms and definitions
- Strengthening international cooperation and confidence in the field of laboratory medicine by ISO standardization
- Determining the minimum blood volume required for laboratory testing in newborns
- Performance evaluation of large language models with chain-of-thought reasoning ability in clinical laboratory case interpretation
- Vancomycin assay interference: low-level IgM paraprotein disrupts Siemens Atellica® CH VANC assay
- Dr. Morley Donald Hollenberg. An extraordinary scientist, teacher and mentor